«3. Medizinische Klinik und Poliklinik – Hämatologische Forschung Cks1 is a critical regulator of hematopoietic stem cell cycling, quiescence and ...»
145. Wang, I.C., et al., Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol, 2005. 25(24): p. 10875-94.
146. Rother, K., et al., Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73. Cell Cycle, 2007. 6(7): p.
147. Wang, W., et al., Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. Oncogene, 2004. 23(5): p. 1064-75.
148. Keller, U.B., et al., Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. EMBO J, 2007. 26(10): p.
149. Hattori, T., et al., Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner. Genes Cells, 2003. 8(11): p. 889-96.
150. Bashir, T., et al., Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature, 2004. 428(6979): p. 190-3.
151. Bashir, T. and M. Pagano, Don't skip the G1 phase: how APC/CCdh1 keeps SCFSKP2 in check. Cell Cycle, 2004. 3(7): p. 850-2.
152. Krishnan, A., S.A. Nair, and M.R. Pillai, Loss of cks1 homeostasis deregulates cell division cycle. J Cell Mol Med, 2010. 14(1-2): p. 154-64.
153. Masuda, H., et al., Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains.
Scand J Gastroenterol, 2003. 38(9): p. 942-6.
154. Inui, N., et al., High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun, 2003. 303(3): p. 978-84.
155. Shapira, M., et al., Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.
Cancer, 2004. 100(8): p. 1615-21.
156. Ouellet, V., et al., Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.
Oncogene, 2005. 24(29): p. 4672-87.
157. Slotky, M., et al., The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res, 2005. 7(5): p. R737-44.
158. Wang, X.C., et al., Role of Cks1 amplification and overexpression in breast cancer. Biochem Biophys Res Commun, 2009. 379(4): p. 1107Wang, X.C., et al., Overexpression of Cks1 increases the radiotherapy resistance of esophageal squamous cell carcinoma. J Radiat Res, 2012.
53(1): p. 72-8.
160. Liberal, V., et al., Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins. Proc Natl Acad Sci U S A, 2012. 109(8): p. 2754Pavlides, S.C., et al., Inhibitors of SCF-Skp2/Cks1 E3ligase block
estrogen-induced growth stimulation and degradation of nuclear p27kip1:
therapeutic potential for endometrial cancer. Endocrinology, 2013.
162. Kratzat, S., et al., Cks1 is required for tumor cell proliferation but not
sufficient to induce hematopoietic malignancies. PLoS One, 2012. 7(5):
163. Oostendorp, R.A., et al., Stromal cell lines from mouse aorta-gonadsmesonephros subregions are potent supporters of hematopoietic stem cell activity. Blood, 2002. 99(4): p. 1183-9.
164. Pear, W.S., et al., Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A, 1993. 90(18): p. 8392-6.
165. Palacios, R. and M. Steinmetz, Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell, 1985. 41(3): p.
166. Daley, G.Q. and D. Baltimore, Transformation of an interleukin 3dependent hematopoietic cell line by the chronic myelogenous leukemiaspecific P210bcr/abl protein. Proc Natl Acad Sci U S A, 1988. 85(23): p.
167. Kabarowski, J.H., P.B. Allen, and L.M. Wiedemann, A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.
EMBO J, 1994. 13(24): p. 5887-95.
168. Nakahata, T. and M. Ogawa, Clonal origin of murine hemopoietic colonies with apparent restriction to granuclocyte-macrophagemegakaryocyte (GMM) differentiation. J Cell Physiol, 1982. 111(3): p.
169. Cohen, J.J., et al., Apoptosis and programmed cell death in immunity.
Annu Rev Immunol, 1992. 10: p. 267-93.
170. Lerner, C. and D.E. Harrison, 5-Fluorouracil Spares Hematopoietic StemCells Responsible for Long-Term Repopulation. Experimental Hematology, 1990. 18(2): p. 114-118.
171. Van Zant, G., Studies of hematopoietic stem cells spared by 5fluorouracil. J Exp Med, 1984. 159(3): p. 679-90.
172. Spruck, C., et al., A CDK-independent function of mammalian Cks1:
Targeting of SCFSkp2 to the CDK inhibitor p27(Kip1). Molecular Cell, 2001. 7(3): p. 639-650.
173. Morita, Y., H. Ema, and H. Nakauchi, Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. Journal of Experimental Medicine, 2010. 207(6): p. 1173-82.
174. Ema, H., et al., In vitro self-renewal division of hematopoietic stem cells.
J Exp Med, 2000. 192(9): p. 1281-8.
175. McKenna, H.J., et al., Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood, 2000. 95(11): p. 3489-97.
176. Audet, J., et al., Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotechnol Bioeng, 2002. 80(4): p. 393-404.
177. Hoellein, A., et al., Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression. Mol Cell Biol, 2012. 32(13): p.
178. Lerner, C. and D.E. Harrison, 5-Fluorouracil spares hemopoietic stem
cells responsible for long-term repopulation. Exp Hematol, 1990. 18(2):
179. Harrison, D.E. and C.P. Lerner, Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood, 1991. 78(5): p. 1237-40.
180. Randall, T.D. and I.L. Weissman, Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood, 1997. 89(10): p. 3596-606.
181. Johnson, J.J., et al., Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
Blood, 2003. 101(8): p. 3229-35.
182. Hao, B., et al., Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Mol Cell, 2005. 20(1): p. 9Soeiro, I., et al., p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol Cell Biol, 2006. 26(16): p. 6170-84.
184. Cheng, T., et al., Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med, 2000. 6(11): p. 1235-40.
185. Perrotti, D., et al., Chronic myeloid leukemia: mechanisms of blastic transformation. Journal of Clinical Investigation, 2010. 120(7): p. 2254Ren, R., Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer, 2005. 5(3): p. 172-83.
187. Affer, M., et al., Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities. J Oncol, 2011. 2011: p.
188. Bruennert, D., et al., Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy. Leukemia, 2009. 23(5): p. 983-5.
189. Gordon, M.Y., Human haemopoietic stem cell assays. Blood Rev, 1993.
7(3): p. 190-7.
190. Dijkers, P.F., et al., Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol, 2000. 20(24): p. 9138-48.
191. Darzynkiewicz, Z., et al., Fluorochrome-labeled inhibitors of caspases:
convenient in vitro and in vivo markers of apoptotic cells for cytometric analysis. Methods Mol Biol, 2011. 682: p. 103-14.
192. Kiyokawa, H., et al., Enhanced growth of mice lacking the cyclindependent kinase inhibitor function of p27(Kip1). Cell, 1996. 85(5): p.
193. Nakayama, K., et al., Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Cell, 1996. 85(5): p. 707-20.
194. Slingerland, J. and M. Pagano, Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol, 2000. 183(1): p. 10-7.
195. Oguro, H. and A. Iwama, Life and death in hematopoietic stem cells. Curr Opin Immunol, 2007. 19(5): p. 503-9.
196. Skaar, J.R., J.K. Pagan, and M. Pagano, Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol, 2013.
14(6): p. 369-81.
197. Rodriguez, S., et al., The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs. Blood, 2011. 117(24): p.
198. Wang, J., et al., The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal. Blood, 2011. 118(20): p. 5429-38.
199. Karin, M. and Y. Ben-Neriah, Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol, 2000. 18: p. 621-63.
200. Fuchs, S.Y., et al., HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylationdependent degradation of IkappaB and beta-catenin. Oncogene, 1999.
18(12): p. 2039-46.
201. Marti, A., et al., Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol, 1999. 1(1): p. 14-9.
202. Gilmore, T.D., Introduction to NF-kappaB: players, pathways, perspectives. Oncogene, 2006. 25(51): p. 6680-4.
203. Zhao, C., et al., Noncanonical NF-kappaB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions.
Stem Cells, 2012. 30(4): p. 709-18.
204. Sun, S.C., The noncanonical NF-kappaB pathway. Immunol Rev, 2012.
246(1): p. 125-40.
205. Kim, J.A., et al., Identification of a stroma-mediated Wnt/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche. Stem Cells, 2009. 27(6): p. 1318-29.
206. Hoellein, A., et al., Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression. Molecular and Cellular Biology, 2012. 32(13): p. 2416-27.
207. Muller-Sieburg, C.E., et al., Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. Blood, 2002. 100(4): p. 1302-9.
208. Dykstra, B., et al., Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell, 2007. 1(2): p. 218-29.
209. Wang, J., A.G. Muntean, and J.L. Hess, ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood, 2012. 119(5): p.
210. Rathinam, C., et al., The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells. Genes Dev, 2008. 22(8): p.
211. Rathinam, C., L.E. Matesic, and R.A. Flavell, The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells. Nat Immunol, 2011. 12(5): p. 399-407.
212. Takubo, K., et al., Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell, 2010. 7(3): p. 391-402.
213. Kimura, S., et al., Hematopoietic stem cell deficiencies in mice lacking cMpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A, 1998.
95(3): p. 1195-200.
214. Dao, K.H., et al., FANCL ubiquitinates beta-catenin and enhances its nuclear function. Blood, 2012. 120(2): p. 323-34.
215. Thompson, B.J., et al., Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med, 2008. 205(6): p. 1395-408.
216. Dao, K.H., et al., The PI3K/Akt1 pathway enhances steady-state levels of FANCL. Mol Biol Cell, 2013. 24(16): p. 2582-92.
217. Wilson, A., et al., c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev, 2004. 18(22): p.
218. Frescas, D. and M. Pagano, Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer, 2008. 8(6): p. 438-49.
219. Laurenti, E., et al., Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell, 2008. 3(6): p. 611-24.
220. Bungartz, G., et al., NF-Y is necessary for hematopoietic stem cell proliferation and survival. Blood, 2012. 119(6): p. 1380-9.
221. Simon, K.E., H.H. Cha, and G.L. Firestone, Transforming growth factor beta down-regulation of CKShs1 transcripts in growth-inhibited epithelial cells. Cell Growth Differ, 1995. 6(10): p. 1261-9.
222. Wu, J., et al., Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex. Oncogene, 2013. 32(1): p. 78-85.
223. Brunet, A., et al., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 1999. 96(6): p. 857-68.
224. Brunet, A., et al., Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Mol Cell Biol, 2001. 21(3): p. 952-65.
225. Raaijmakers, M.H., et al., Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature, 2010. 464(7290): p.
226. Zhan, F., et al., CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1dependent and -independent mechanisms. Blood, 2007. 109(11): p.
227. Nagler, R.M., et al., The expression and prognostic significance of Cks1 in salivary cancer. Cancer Invest, 2009. 27(5): p. 512-20.
228. Gomez-Casares, M.T., et al., MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.). Oncogene, 2013. 32(17): p. 2239-46.
229. Chan, C.H., et al., Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression. Cell, 2013. 154(3): p. 556-68.
230. Old, J.B., et al., Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Mol Cancer Res, 2010. 8(3): p. 353-62.
1. Höglund A, Nilsson LM, Muralidharan SV, Hasvold LA, Merta P, Rudelius M, Nikolova V, Keller U, Nilsson JA (2011) “Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells”. Clin Cancer Res; 17 (22):7067-79.
2. Kratzat S, Nikolova V, Miething C, Hoellein A, Schoeffmann S, Gorka O, Pietschmann E, Illert AL, Ruland J, Peschel C, Nilsson J, Duyster J, Keller U (2012) “Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies.” PLos ONE; 7(5):e37433.
3. Baumann U, Fernández-Sáiz V, Lemeer S, Rudelius M, Engel K, Tomiatti V, Targosz B, Knorn A, Braun M, Perner S, Klapper S, Dreyling M, Miething C, Leitges M, Peschel C, Keller U, Kuster B and Florian Bassermann “PKCδ directs SCFFbxo25 mediated degradation of Hax-1 to regulate cell survival and suppress lymphomagenesis” Submitted Manuscript.
4. Tomiatti V, Pietschmann E, Kratzat S, Hoellein A, Quintanilla-Fend L, von Bubnoff N, Peschel C, Oostendorp R, and Keller U “Cks1 is a critical regulator of hematopoietic stem cell cycling, quiescence and homeostasis, operating upstream of Cdk inhibitors” Submitted Manuscript.
10. Acknowledgements Numerous people have supported me during this project with their help, knowledge and encouragement and I feel very grateful for all their support.
There are some people who I would especially like to point out.
My gratitude goes out to Prof. Dr. Ulrich Keller for letting me join his group and allowing me to produce this thesis under his supervision. Also, I would like to thank Prof. Dr. Christian Peschel, director of the III. Medical Clinic at the Klinikum Rechts der Isar. The scientific environment there was important for succeeding with the project.
Especially, I wish to thank my mentor, PD Dr. Robert Oostendorp. He was advising me on my experiments and I learned a lot from him. The discussions with Robert were extremely helpful for the evaluation of the results.
I would like to thank Prof. Dr. Angelika Schnieke for accepting to become my second adviser, thus allowing me to complete my dissertation as a member of the medical graduate center.
I wish to thank all of my colleagues for the friendly and productive atmosphere in the lab. Especially I would like to thank Susanne and Steffi who were always willing to help me with experiments. Working with Madlen and Susanne made the work days more pleasant. Special thank goes to Susanne and Alex for proofreading my dissertation.
I wish to express my deepest gratitude to my parents, Pavlina and Georgi and my brother, Hristo. They supported me and believed in me through all the years of studying and working abroad.
Finally, I would like to thank my loving husband, Sebastian. His support gave